AKT1 and neoplasm: PTEN acts as a specific protein‐phospholipid phosphatase to inhibit the Ras/MAPK and Akt/PKB pathways.39 Upregulation of both tumor suppressors was also responsible for the antitumor effects of SAHA/MG132 treatment.